Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 6Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Testicular Neoplasms 1Surgery 1Stress, Psychological 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Seminoma 1Sarcoma 1Recurrence 1Postoperative Complications 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Ductal Adenocarcinoma 1Ovarian Neoplasms 1Neoplasms 1Neoplasm, Residual 1Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer 1Multiple Myeloma 1Medulloblastoma 1Lung Neoplasms 1Liposarcoma 1Leiomyosarcoma 1Intermittent Fasting 1Head and Neck Neoplasms 1HER2-positive Breast Cancer 1Esophageal Squamous Cell Carcinoma 1Carcinoma, Ovarian Epithelial 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1

Interventions

Gemcitabine 31Cisplatin 22pembrolizumab 21Magnetic Resonance Spectroscopy 18Specimen Handling 16durvalumab 11Mitomycin 10enfortumab vedotin 9avelumab 9Cystoscopy 9Nivolumab 8Fluorouracil 8Carboplatin 8Radiation 7Cystectomy 7atezolizumab 5Transurethral Resection of Bladder 5Radiotherapy 5Mitozytrex 5Immunoglobulin G 5Docetaxel 5Disulfides 5Biopsy 5tremelimumab 4sacituzumab govitecan 4erdafitinib 4dehydroftorafur 4Platinum 41,2-diaminocyclohexaneplatinum II citrate 4disitamab vedotin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Neoadjuvant Therapy × 90 days × Clear all
NCT06290687 2026-06-05

Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy

Case Comprehensive Cancer Center

Phase 2 Recruiting
40 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡